These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1433895)

  • 21. [Morphological and biochemical features of fungi isolated from patients with renal failure].
    Drozdowska A
    Wiad Parazytol; 2007; 53(2):145-8. PubMed ID: 17912812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
    Kauffman CA; Vazquez JA; Sobel JD; Gallis HA; McKinsey DS; Karchmer AW; Sugar AM; Sharkey PK; Wise GJ; Mangi R; Mosher A; Lee JY; Dismukes WE
    Clin Infect Dis; 2000 Jan; 30(1):14-8. PubMed ID: 10619726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
    Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
    J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of fungal infections with flucytosine.
    Harder EJ; Hermans PE
    Arch Intern Med; 1975 Feb; 135(2):231-7. PubMed ID: 1096840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichosporon beigelii infection: experience in a regional burn center.
    Cawley MJ; Braxton GR; Haith LR; Reilly KJ; Guilday RE; Patton ML
    Burns; 2000 Aug; 26(5):483-6. PubMed ID: 10812273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies.
    Kostiala AA; Kostiala I
    J Med Microbiol; 1984 Oct; 18(2):249-54. PubMed ID: 6387127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of complicated urinary tract infections caused by fungi].
    Kawada Y; Shimizu Y; Horie M; Tokuyama H; Matsuda S; Nishiura T
    Jpn J Antibiot; 1984 Mar; 37(3):285-9. PubMed ID: 6330394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
    Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
    J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fungi in patients with diabetes mellitus type 2: prevalence, species of isolated strains].
    Maciejewska A; Jaskółowska A; Kwaśniewska J
    Wiad Parazytol; 2004; 50(2):163-70. PubMed ID: 16859020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits.
    Hughes CE; Peterson LR; Beggs WH; Gerding DN
    J Antimicrob Chemother; 1986 Jul; 18(1):65-72. PubMed ID: 3531144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichosporon beigelii funguria in renal transplant recipients.
    Lussier N; Laverdière M; Delorme J; Weiss K; Dandavino R
    Clin Infect Dis; 2000 Nov; 31(5):1299-301. PubMed ID: 11073770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketoconazole therapy for fungal urinary tract infections.
    Graybill JR; Galgiani JN; Jorgensen JH; Strandberg DA
    J Urol; 1983 Jan; 129(1):68-70. PubMed ID: 6298476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Laboratory and clinical study of intravenous miconazole].
    Sawae Y; Okada K; Kumagai Y
    Jpn J Antibiot; 1987 Feb; 40(2):271-83. PubMed ID: 3599380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of systemic fungal infections.
    Rolston K
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):11-4. PubMed ID: 11757845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of fungal isolates in patients with chronic diarrhea at a tertiary care hospital in north India.
    Banerjee P; Kaur R; Uppal B
    J Mycol Med; 2013 Mar; 23(1):21-6. PubMed ID: 23375861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fungal infections of the lower urinary tracts in urological patients].
    Karabak BI; Popov SV; Shmel'kov IIu
    Ter Arkh; 2007; 79(11):49-52. PubMed ID: 18219974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.